Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI)
MRVI Stock Predictions and Ratings
WSX Rating:
HOLD
WSX Forecast (1yr):
1.20%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-46.60%
MRVI Stock Analysis
MRVI
PE Ratio:
MRVI
PEG Ratio:
Not Available
MRVI
Forward EPS Growth (12 month):
0.00%
MRVI
PS Ratio:
6.5
MRVI
PSG Ratio:
0.9
MRVI
Forward Revenue Growth (12 month):
7.00%
MRVI Articles
No data was found